Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221437
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlvarez-Sierra, Daniel-
dc.contributor.authorMartínez-Gallo, Mónica-
dc.contributor.authorSánchez-Montalvá, Adrián-
dc.contributor.authorFernández Sanmartín, Marco-Antonio-
dc.contributor.authorColobran, Roger-
dc.contributor.authorEspinosa-Pereiro, Juan-
dc.contributor.authorPoyatos-Canton, Elisabet-
dc.contributor.authorZurera-Egea, Coral-
dc.contributor.authorSànchez, Àlex (Sànchez Pla)-
dc.contributor.authorViolán, Concepción-
dc.contributor.authorParra, Rafael-
dc.contributor.authorAlzayat, Hammad-
dc.contributor.authorVivancos, Ana-
dc.contributor.authorMorandeira-Rego, Francisco-
dc.contributor.authorUrban-Vargas, Blanca-
dc.contributor.authorMartínez-Cáceres, Eva-
dc.contributor.authorHernández-González, Manuel-
dc.contributor.authorBas Minguet, Jordi-
dc.contributor.authorKatsikis, Peter-
dc.contributor.authorTeniente-Serra, Aina-
dc.contributor.authorPujol Borrell, Ricardo-
dc.date.accessioned2025-06-06T17:44:13Z-
dc.date.available2025-06-06T17:44:13Z-
dc.date.issued2025-03-01-
dc.identifier.issn1521-6616-
dc.identifier.urihttps://hdl.handle.net/2445/221437-
dc.description.abstractThe antibody response to SARS-CoV-2 does not follow the immunoglobulin isotype pattern of primary responses, conflicting with the current interpretation of COVID-19. Methods: Prospective cohort study of 191 SARS-CoV-2 infection cases and 44 controls from the second wave of COVID-19. The study stratified patients by severity and analyzed the trajectories of SARS-CoV-2 antibodies and multiple immune variables. Results: Isotype-specific antibody time course profiles to SARS-CoV-2 revealed a pattern of recall response in 94.2 % of cases. The time course profiles of plasmablasts, B cells, cTfh high-resolution subsets, and cytokines indicated a secondary response. The transcriptomic data showed that this cohort is strictly comparable to contemporary cohorts. Conclusions: In most cases, the immune response to SARS-CoV-2 is a recall response. This constitutes a favorable scenario for most COVID-19 cases to be subjected to immune imprinting by endemic coronavirus, which, in turn, can influence the immune response to SARS-CoV-2.-
dc.format.extent17 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier B.V.-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.clim.2025.110429-
dc.relation.ispartofClinical Immunology, 2025, vol. 272-
dc.relation.urihttps://doi.org/10.1016/j.clim.2025.110429-
dc.rightscc-by-nc (c) Alvarez-Sierra, Daniel et al., 2025-
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationCOVID-19-
dc.subject.classificationAdults-
dc.subject.classificationImmunoglobulines-
dc.subject.classificationLimfòcits-
dc.subject.otherCOVID-19-
dc.subject.otherAdulthood-
dc.subject.otherImmunoglobulins-
dc.subject.otherLymphocytes-
dc.titleThe immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec758781-
dc.date.updated2025-06-06T17:44:13Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid39842683-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
894557.pdf7.31 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons